By Zachary Stieber The U.S. Food and Drug Administration (FDA) has changed the end date for a key study on post-vaccination heart inflammation without notifying the public. Pfizer was supposed to complete a study on the occurrence of subclinical myocarditis, or heart inflammation, after receipt of its COVID-19 vaccine. The completion date was listed by the FDA in 2021 as […]
Tag: Myopericarditis
Myopericarditis is a condition characterized by inflammation of the pericardium (pericarditis) with concurrent involvement of the adjacent myocardial layer. Myopericarditis usually presents similarly to pericarditis with chest pain, fever, and shortness of breath.
